{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:08:17Z","timestamp":1792382897615,"version":"4.4.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/ndt\/gfx222","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T11:08:58Z","timestamp":1495710538000},"page":"65-75","source":"Crossref","is-referenced-by-count":44,"title":["Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems"],"prefix":"10.1093","volume":"33","author":[{"given":"Cesira","family":"Cafiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomina","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Chaoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Oranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Colucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B","family":"Pertosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,21]]},"reference":[{"key":"key\n\t\t\t\t20180112080207_gfx222-B1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3949\/ccjm.81a.13046","article-title":"Managing advanced chronic kidney disease: a primary care guide","volume":"81","year":"2014","journal-title":"Cleve Clin J Med"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000351758","article-title":"Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","year":"2013","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5527\/wjn.v2.i2.31","article-title":"Inflammatory status in chronic renal failure: the role of homocysteinemia and pro-inflammatory cytokines","volume":"2","year":"2013","journal-title":"World J Nephrol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/j.2040-4603.2013.tb00511.x","article-title":"Immune and inflammatory role in renal disease","volume":"3","year":"2013","journal-title":"Compr Physiol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B5","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00198-015-3233-8","article-title":"Inflammation and the bone-vascular axis in end-stage renal disease","volume":"27","year":"2016","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B7","first-page":"49","article-title":"Molecular biology of bone remodelling","volume":"5","year":"2008","journal-title":"Clin Cases Miner Bone Metab"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B8","first-page":"125705","article-title":"The role of inflammatory cytokines, the RANKL\/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis","volume":"2013","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B10","first-page":"S1","article-title":"Biology of RANK, RANKL, and osteoprotegerin","volume":"9(Suppl 1)","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jb\/mvt049","article-title":"Immunology and bone","volume":"154","year":"2013","journal-title":"J Biochem"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B12","first-page":"720504","article-title":"The interplay between the bone and the immune system","volume":"2013","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1359\/jbmr.070207","article-title":"Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women","volume":"22","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.38218","article-title":"Combination of tumor necrosis factor alpha and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo","volume":"66","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B15","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.18632\/oncotarget.2633","article-title":"LIGHT\/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease","volume":"5","year":"2014","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.21821","article-title":"LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis","volume":"54","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.yexmp.2013.01.003","article-title":"Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT","volume":"94","year":"2013","journal-title":"Exp Mol Pathol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12026-012-8297-3","article-title":"The three human monocyte subsets: implications for health and disease","volume":"53","year":"2012","journal-title":"Immunol Res"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B19","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/ar2915","article-title":"CD16 (FcR\u03b3III) as a potential marker of osteoclast precursors in psoriatic arthritis","volume":"12","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.33418","article-title":"The CD14(bright)CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population","volume":"64","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B21","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jacc.2012.07.019","article-title":"CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography","volume":"60","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B22","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/ndt\/gfq012","article-title":"Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease","volume":"25","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrneph.2012.41","article-title":"Monocyte subpopulations and cardiovascular risk in chronic kidney disease","volume":"8","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B24","doi-asserted-by":"crossref","first-page":"e14167","DOI":"10.1371\/journal.pone.0014167","article-title":"Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase","volume":"5","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B25","first-page":"783","article-title":"Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry","volume":"22","year":"2009","journal-title":"J Nephrol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B26","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","author":"Kidney Disease: Improving Global Outcomes CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B27","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s00264-014-2386-y","article-title":"Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis","volume":"38","year":"2014","journal-title":"Int Orthop"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B28","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1902\/jop.2005.76.10.1675","article-title":"T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients","volume":"76","year":"2005","journal-title":"J Periodontol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B29","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1210\/jc.2008-2446","article-title":"Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-\u03baB ligand\/osteoprotegerin imbalance","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B30","first-page":"199","article-title":"OPG\/RANK\/RANKL signaling system and its significance in nephrology","volume":"47","year":"2009","journal-title":"Folia Histochem Cytobiol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4110\/in.2013.13.4.111","article-title":"Osteoimmunology: a brief introduction","volume":"13","year":"2013","journal-title":"Immune Netw"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.20452\/pamw.1782","article-title":"Osteoporosis in mineral and bone disorders of chronic kidney disease","volume":"123","year":"2013","journal-title":"Pol Arch Med Wewn"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B33","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","year":"2006","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.abb.2010.06.028","article-title":"The bone and the kidney","volume":"503","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5301\/jn.5000212","article-title":"Osteoporosis and adynamic bone in chronic kidney disease","volume":"26","year":"2013","journal-title":"J Nephrol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B36","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B37","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","year":"2011","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2369-13-134","article-title":"Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study","volume":"13","year":"2012","journal-title":"BMC Nephrol"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B39","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0272-6386(04)00958-8","article-title":"Increased risk of mortality associated with hip fracture in the dialysis population","volume":"44","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B40","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3349\/ymj.2016.57.4.905","article-title":"Assessment of denosumab in Korean postmenopausal women with osteoporosis: randomized, double-blind, placebo-controlled trial with open-label extension","volume":"57","year":"2016","journal-title":"Yonsei Med J"},{"key":"key\n\t\t\t\t20180112080207_gfx222-B41","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/annrheumdis-2015-208052","article-title":"Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with Rheumatoid arthritis on methotrexate to validate inhibitory effect on bone Erosion (DRIVE) \u2014 a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial","volume":"75","year":"2016","journal-title":"Ann Rheum Dis"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/33\/1\/65\/23447485\/gfx222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T20:06:06Z","timestamp":1750277166000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/33\/1\/65\/4002780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,7,21]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfx222","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,7,21]]}}}